valproic acid has been researched along with glucagon-like peptide 1 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Anton, SD; Greenway, FL; Han, H; Martin, CK; Smith, SR | 1 |
| Ebenbichler, CF; Laimer, M; Luef, G; Rauchenzauner, M; Salzmann, K; Sandhofer, A; Sturm, W; Tschoner, A; Walser, G; Wiedmann, M | 1 |
| Altun, A; Çiçekli, MN; Günaydın, C; Tiryaki, ES | 1 |
1 trial(s) available for valproic acid and glucagon-like peptide 1
| Article | Year |
|---|---|
Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial.
Topics: Adolescent; Adult; Anticonvulsants; Attitude; Blood Glucose; Body Weight; Creatinine; Delayed-Action Preparations; Eating; Feeding Behavior; Female; Ghrelin; Glucagon-Like Peptide 1; Humans; Insulin; Leptin; Lipids; Male; Middle Aged; Motor Activity; Patient Compliance; Peptide Fragments; Peptide YY; Serum Albumin; Valproic Acid | 2009 |
2 other study(ies) available for valproic acid and glucagon-like peptide 1
| Article | Year |
|---|---|
The novel insulin resistance parameters RBP4 and GLP-1 in patients treated with valproic acid: just a sidestep?
Topics: Adolescent; Adult; Aged; Anticonvulsants; Child; Diabetes Mellitus, Type 2; Fatty Liver; Female; Glucagon-Like Peptide 1; Glucose; Homeostasis; Humans; Insulin Resistance; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Retinol-Binding Proteins, Plasma; Valproic Acid; Young Adult | 2013 |
GLP-1 agonist liraglutide improves ouabain-induced mania and depressive state
Topics: Animals; Antioxidants; Glucagon-Like Peptide 1; Glutathione; Glycogen Synthase Kinase 3 beta; Liraglutide; Lithium; Mania; Ouabain; Oxidants; Rats; Sucrose; Valproic Acid | 2022 |